Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/Safety of TUR01 vs Humira in Healthy Subjects
NCT04439929Phase 1Completed
- Sponsor
- Turgut Pharmaceuticals
- Start
- Jul 2019
- Primary completion
- Jan 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of TUR01 in rheumatoid arthritis (RA) (2 arms), sponsored by Turgut Pharmaceuticals. Primary endpoints: Area under the concentration-time curve from time 0 to infinity and Maximum serum concentration. Started Jul 2019; status: completed.
02
Drugs
TUR01
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT04439929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04439929.